Praxis Precision Medicines Announces Positive Topline Results from Two Pivotal Phase 3 Studies of Ulixacaltamide HCl in the Essential3 Program for Essential Tremor Biotech Investing
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases Biotech Investing
Rakovina Therapeutics to Present New Data Highlighting Novel ATR Inhibitor with CNS Penetration at the AACR-NCI-EORTC International Conference Biotech Investing
Innovotech makes strategic investments to expand analytical laboratory services and offers an unsecured convertible debenture for $200,000. Biotech Investing
Acadia Pharmaceuticals to Announce Third Quarter 2025 Financial Results on November 5, 2025 Biotech Investing
Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma Biotech Investing
Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025 Biotech Investing
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal Biotech Investing
Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption Biotech Investing
PharmaTher Announces KetAImine - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505 NDA Filings Biotech Investing
